MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 153 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,118,000 | -4.1% | 363,154 | +27.1% | 0.00% | 0.0% |
| Q4 2016 | $1,166,000 | -48.6% | 285,799 | -32.1% | 0.00% | -57.1% |
| Q2 2016 | $2,270,000 | -35.4% | 421,079 | +0.3% | 0.01% | -36.4% |
| Q1 2016 | $3,513,000 | +4.0% | 419,708 | -1.8% | 0.01% | +10.0% |
| Q4 2015 | $3,377,000 | -16.7% | 427,476 | -10.3% | 0.01% | -16.7% |
| Q3 2015 | $4,053,000 | -34.2% | 476,339 | -4.3% | 0.01% | -20.0% |
| Q2 2015 | $6,155,000 | +23.9% | 497,711 | +19.0% | 0.02% | +25.0% |
| Q1 2015 | $4,968,000 | +29.5% | 418,169 | +23.2% | 0.01% | +20.0% |
| Q4 2014 | $3,835,000 | – | 339,372 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 514,853 | $2,595,000 | 2.23% |
| GARRISON BRADFORD & ASSOCIATES INC | 98,001 | $494,000 | 0.48% |
| Catalyst Capital Advisors LLC | 380,896 | $1,920,000 | 0.44% |
| Knoll Capital Management, LLC | 160,585 | $809,000 | 0.42% |
| Tekla Capital Management LLC | 757,050 | $3,816,000 | 0.38% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 524,800 | $2,645,000 | 0.13% |
| Integre Asset Management, LLC | 103,493 | $522,000 | 0.12% |
| CAMBRIDGE TRUST CO | 220,003 | $1,109,000 | 0.10% |
| JAMISON EATON & WOOD INC /NJ | 62,782 | $316,000 | 0.09% |
| STONERIDGE INVESTMENT PARTNERS LLC | 88,304 | $445,000 | 0.09% |